A0A1U9X7H8 (A0A1U9X7H8_HUMAN) Homo sapiens (Human)
Complement factor B UniProtKBInterProInteractive Modelling
764 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P00751
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of Complement C3b in complex with Factors B and D |
Heteromer P00746; P00751; P01024; | 2×NAG; 1×NAG; 2×MG; 2×NAG; 1×GOL; | ||||
| Assess | ||||||
| Structure of the nanobody stablized properdin bound alternative pathway proconvertase C3b:FB:FP |
Heteromer P00751; P01024; P27918; | 3×NAG; 3×FUC; 2×NAG; 6×MAN; 1×NAG; 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of Complement C3b in Complex with Factor B |
Heteromer P00751; P01024; | 2×NAG; 1×NI; | ||||
| Assess | ||||||
| Cobra Venom Factor (CVF) in complex with human factor B |
Heteromer P00751; Q91132; | 1×NAG; 3×NAG; 2×MG; 1×K; 2×P6G; 5×PO4; | ||||
| Assess | ||||||
| Cobra Venom Factor (CVF) in complex with human factor B |
Heteromer P00751; Q91132; | 1×NAG; 3×NAG; 2×MG; | ||||
| Assess | ||||||
| Structure of the C3bB proconvertase in complex with lufaxin and factor Xa |
Heteromer P00742; P00751; P01024; Q5WPU8; | 1×NAG; 1×MG; 2×NAG; | ||||
| Assess | ||||||
| Structure of the C3bB proconvertase in complex with lufaxin |
Heteromer P00751; P01024; Q5WPU8; | 3×NAG; 4×NAG; | ||||
| Assess | ||||||
| C3 convertase (C3bBb) stabilized by SCIN |
Heteromer P00751; P01024; Q6GFB4; | 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 1×BMA; 1×MAN; 2×MG; 1×NAG; | ||||
| Assess | ||||||
| Structure of the SCIN stabilized C3bBb convertase bound to properdin |
Heteromer P00751; P01024; P27918; Q931M7; | 4×FUC; 2×NAG; 8×NAG; 18×MAN; 2×MG; | ||||
| Assess | ||||||
| Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanob… |
Heteromer P00751; P01024; P27918; Q931M7; | 5×FUC; 2×NAG; 8×NAG; 21×MAN; 2×MG; | ||||
| Assess | ||||||
| FACTOR B SERINE PROTEASE DOMAIN | homo-2-mer | |||||
| Assess | ||||||
| Human Complement factor B | monomer | 1×NAG; 1×NAG; 2×NAG; 13×GOL; | ||||
| Assess | ||||||
| Human Complement Factor B Inhibited by a Slow Off-Rate Modified Aptamer of 29 Bases | monomer | |||||
| Assess | ||||||
| Human Complement Factor B Inhibited by a Slow Off-Rate Modified Aptamer of 31 Bases | monomer | |||||
| Assess | ||||||
| Crystal Structure Analysis of the Bb segment of Factor B | monomer | 2×IOD; 7×NA; 1×CO; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the Bb segment of Factor B complexed with 4-guanidinobenzoic acid | monomer | 2×IOD; 7×NA; 1×MG; 1×GBS; | ||||
| Assess | ||||||
| Crystal Structure Analysis of the Bb segment of Factor B complexed with Di-isopropyl-phosphate (DIP) | monomer | 2×IOD; 7×NA; 1×MG; 1×DFP; | ||||
| Assess | ||||||
| Complement factor B protease domain in complex with the reversible inhibitor N-(2-bromo-4-methylnap… | monomer | 3×SO4; 1×JGT; | ||||
| Assess | ||||||
| Complement factor B in complex with (-)-4-(1-((5,7-Dimethyl-1H-indol-4-yl)methyl)piperidin-2-yl)ben… | monomer | 2×SO4; 1×MVW; | ||||
| Assess | ||||||
| Complement factor B protease domain in complex with the reversible inhibitor 4-((2S,4S)-4-ethoxy-1-… | monomer | 2×SO4; 1×JGQ; | ||||
| Assess | ||||||
| Complement factor B protease domain in complex with the reversible inhibitor ((2S,4S)-1-((5,7-dimet… | monomer | 3×SO4; 1×JGN; | ||||
| Assess | ||||||
| Complement factor B in complex with (S)-5,7-Dimethyl-4-((2-phenylpiperidin-1-yl)methyl)-1H-indole | monomer | 2×SO4; 1×MVK; | ||||
| Assess | ||||||
| Complement factor B in complex with 5-Bromo-3-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-7-methyl-1H-i… | monomer | 1×MVZ; 3×SO4; | ||||
| Assess | ||||||
| A domain of Factor B | monomer | 1×MN; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3hrz.1.D | monomer | 0.84 | 99.73 | |||
| Assess | ||||||